Sweden

 

Diaverum deal: An analysis

Last week the news broke that Abu Dhabi sovereign wealth fund Mubadala Investment Co might be set to buy Swedish multinational dialysis firm Diaverum for a reported $2.5bn. HBI speaks to an operator source who thinks this would be a good price for the seller - and hears why some investors are switched off by dialysis.
April 6, 2023

The future of telehealth is partly in bricks and mortar

With Covid hopefully on the wane, the firm foothold digital health established in many markets is looking a little less stable. What next for groups like Swedish telehealth firm Kry? HBI speaks to two experts and Kry itself to find out why telehealth is getting physical.
March 22, 2023

Cinven looks to take Synlab private as Covid boost falters

Frankfurt-listed Synlab could be about to be taken private following a non-binding full takeover offer earlier this week. With its full year results released yesterday and facing questions about its plans, HBI asks market experts what they think of the move.
March 17, 2023

EMR boost in Germany and Sweden

Sweden is looking to centralise more data – primarily to boost the efficiency of its electronic medical records (EMR). Meanwhile German health minister Karl Lauterbach is making the German patient medical records an opt-out system to boost uptake. HBI speaks to experts to find out how these developments will affect healthcare services.
March 16, 2023

Employers driving up Scandi PMI

Despite its reputation for excellent public healthcare and an economy as close to socialist as a capitalist country can be, private medical insurance (PMI) is on the up in Scandinavia. HBI speaks to three operators to find out more.
February 24, 2023

Good growth but profit problems for Terveystalo and Attendo in 2022

Elderly care group Attendo and outpatient group Terveystalo, two pan-Nordic giants with over a billion in revenue, struggled to turn a profit in 2022. This was despite strong (organic) revenue growth, set against a backdrop of rising inflation. HBI looks at the newly released results of both groups to find out more. 
February 24, 2023

Humana’s share price plummets after allegations

Pan-Nordic Swedish care company Humana Group has seen its share price plummet 57% since the end of January, after Sweden’s health care inspectorate temporarily revoked its licence to provide personal assistance in Sweden. 
February 10, 2023

Interview: Lars Dahle, founder, Dignio

Having spent the last 10 years of his life building a multi-million revenue company, Dignio founder Lars Dahle has found the last week since he stepped down as CEO rather quiet. HBI catches up with him in reflective mood, as he chats about how he built the business up, and how he really feels about leaving his company's future in others' hands.
November 10, 2022
Newer posts
Older posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us